CORLINE BIOMEDICAL AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.3 SEK | +3.20% |
|
+5.61% | -24.16% |
| 30/04 | Corline Biomedical AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 14/02 | Corline Biomedical AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Specialty & Advanced Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 22.59M | - | - | - | - | - | |
| 79.25B | ||||||
| 9.15B | ||||||
| 4.46B | - | - | ||||
| 4.9B | ||||||
| 4.09B |
